Insight that Drives the Boardroom

Stay ahead with data-backed research, governance analysis, and expert commentary for investors, activists, and corporate leaders.

Activism & Governance

Can Redfin Find Its Way to Profitability?

Redfin CEO Glenn Kelman says the real estate brokerage will post an operating profit this year. Headcount reductions are a good start, but there’s still plenty of work to do to stabilize troubling iBuying trends.

Governance Alert: FedEx

FedEx (FDX) is making some shareholder-friendly moves, including an over 50% dividend hike, adding two independent directors, and a TSR-based executive compensation metric. We applaud the changes, but now the real work begins. Can a new CEO and refreshed board improve margins?

5 Long-Tenured CEOs that Need to Turn Things Around

While COVID-related issues are abating, it’s no secret that many companies are still struggling to find their footing. We take a close-up look at 5 long-tenured CEOs (+ 1 co-CEO) that are facing big negative 3-year returns.

Founder Richard Schulze Bets Big on BBY Stock

Best Buy (BBY) founder and director Richard Schulze just bought almost $20 million in stock. Meanwhile, Target (TGT) lowers guidance again, citing excess inventory concerns.

SPAC & IPO Analysis

Daily SPAC Update – March 18, 2025

Hennessey Capital Deal Vote and Metal Sky Star Extension Vote Set. Northview Acquisition Extensino Vote. Quartsea Acquisition $72M IPO.

Daily SPAC Update – March 17, 2025

Target Global and VenHub Fight Over Deal Termination. Hennessey Capital VI + Namib Minerals Deal Vote Set. 3 More SPAC Delistings.

Daily SPAC Update – March 14, 2025

Finnovate Delays Deal Vote Again. Bannix Acquisition (BNIX) Extends. Bukit Jalil (BUJA) and Sk Growth (SKGR) Votes Set. Columbus Acquisition (COLA) Separate Trading. 

Daily SPAC Update – March 12, 2025

Perception Capital IV / Blue Gold Deal Approved. Inflection Point (IPXX) Forward Purchase Agreement. K&F Growth Separate Trading Starts Tomorrow.

Daily SPAC Update – March 11, 2025

USA Rare Earth Deal with Inflection Point Acquisition II Approved. Liminatus Pharma + Iris Acquisition Approved. Aquaron Delisting. SK Growth and Oak Woods Get Vote Dates.

Daily SPAC Update – March 7, 2025

Newbury Street (NBST) Chasing for $7M Termination Fee. Aimfinity Investment (AIMAU) Sets Deal Vote. Northview (NVAC) Sets Extension Vote. Bannix (BNIX) Extension Vote.

Daily SPAC Update – March 5, 2025

Focus Impact (BHAC) Deal Approved; Expects to Close in March. Relativity Acquisition (RACY) Tries Again with Instinct Brothers.

Daily SPAC Update – March 4, 2025

Iris Acquisition (IRAA) + Liminatus Pharma Deal Vote. Watch for Late 10-Ks. Flag Ship (FSHP) Extends Outside Date to August 28, 2025

Get it In Your Inbox

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.